SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032552
Filing Date
2021-06-11
Accepted
2021-06-11 07:10:31
Documents
17
Period of Report
2021-06-11
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-8k_20210611.htm   iXBRL 8-K 56820
2 EX-99.1 crsp-ex991_11.htm EX-99.1 48679
3 EX-99.2 crsp-ex992_178.htm EX-99.2 14027
4 EX-99.3 crsp-ex993_179.htm EX-99.3 16358
5 GRAPHIC giwcblbwt0li000001.jpg GRAPHIC 1645540
6 GRAPHIC gp42h43ddcnw000001.jpg GRAPHIC 1713611
  Complete submission text file 0001564590-21-032552.txt   4918992

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA crsp-20210611.xsd EX-101.SCH 5776
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20210611_lab.xml EX-101.LAB 18642
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20210611_pre.xml EX-101.PRE 11151
10 EXTRACTED XBRL INSTANCE DOCUMENT crsp-8k_20210611_htm.xml XML 3398
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 211009949
SIC: 2836 Biological Products, (No Diagnostic Substances)